- $699.75m
- $1.06bn
- $4.31bn
- 94
- 95
- 47
- 93
Annual income statement for Hyster-Yale, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,812 | 3,076 | 3,548 | 4,118 | 4,308 |
| Cost of Revenue | |||||
| Gross Profit | 465 | 363 | 434 | 786 | 896 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,762 | 3,228 | 3,587 | 3,910 | 4,063 |
| Operating Profit | 49.9 | -152 | -39.1 | 209 | 245 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 42.2 | -155 | -62.4 | 181 | 219 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 38.5 | -183 | -71.6 | 128 | 144 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 37.1 | -173 | -74.1 | 126 | 142 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 37.1 | -173 | -74.1 | 126 | 142 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.45 | -7.58 | -4.38 | 7.24 | 8.88 |
| Dividends per Share |